Cannabis Investment Report | December 2017
Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.
View the original on the official releaseDocument text
Text is machine OCR and may contain errors. Confirm against the original source above.
Cannabis Investment Report | December 2017
U.S. Legalized Cannabis Market: Consumer Penetration Rate
25% — Path to Federal Legalization
FDA Approves Cannabis-Derived Pharmaceuticals
20% : More States Adopt Medical Cannabis Laws
More States Adopt Recreational Laws
15% FDA Routinely Approves CBD Drugs
FDA Routinely Approves THC Drugs
10% — Federal Government Legalizes Cannabis
5% -
0% -
2016 «2017 «2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Source: Ackrell Capital
Monthly Cannabis Spending
We estimated average monthly spending on cannabis using data provided by dispensaries in states with
recreational laws. We then assigned spending levels (low, moderate and heavy) to each age group of
eligible consumers by state. The resulting weighted averages of monthly consumer spending used in
our analysis are as follows.
U.S. Legalized Cannabis Market: Weighted Average Monthly Consumer Spending
$190
$170
$150 7 Path to Federal Legalization
$130 FDA Approves Cannabis-Derived Pharmaceuticals
More States Adopt Medical Cannabis Laws
$110 :
More States Adopt Recreational Laws
$90 1 FDA Routinely Approves CBD Drugs
FDA Routinely Approves THC Drugs
$70 _ = ——
Federal Government Legalizes Cannabis
$50
2016 «2017 «2018 )§=2019 9 2020. 2021 «2022, 2023) 2024 )9=— 2025. 2026 )3=— 2027 »3= 2028 )3=— 2029 = 2030
Source: Ackrell Capital
110 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC
HOUSE_OVERSIGHT_024746
Have a question about what this document contains?
Ask the documents